human aortic endothelial cells (Cell Applications Inc)
Structured Review

Human Aortic Endothelial Cells, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 94/100, based on 66 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aortic endothelial cells/product/Cell Applications Inc
Average 94 stars, based on 66 article reviews
Images
1) Product Images from "Age and Sex Impact the Role of Thrombospondin‐2 and Thrombospondin‐5 in Response to Hindlimb Ischemia"
Article Title: Age and Sex Impact the Role of Thrombospondin‐2 and Thrombospondin‐5 in Response to Hindlimb Ischemia
Journal: FASEB BioAdvances
doi: 10.1096/fba.2025-00258
Figure Legend Snippet: TSP‐2 inhibits angiogenesis in early passage ECs, and TSP‐5 may be protective against tubule disruption. (A, B) Angiogenesis was assessed by plating ECs overnight on a Matrigel‐based endothelial tubule formation assay and pretreating with or without TSP‐2 (5 μg/mL) or TSP‐5 (5 μg/mL). TSP‐2 inhibited tubule formation in early passage ECs, but TSP‐5 inhibited tubule formation in late passage ECs. (C, D) To assess tubule disruption, EC tubules were allowed to form overnight and then treated for 24 h with TSP‐2 (5 μg/mL) or TSP‐5 (5 μg/mL). TSP‐2 inhibited tubule formation in late passage ECs (D), TSP‐5 increased tubule formation in early passage ECs (C). In the postformation treatment groups, late passage ECs had more tubule disruption than early passage cells. Values are means ± SE. Student's t ‐test performed for analysis, * p < 0.05 compared to nontreatment.
Techniques Used: Disruption, Tube Formation Assay

